Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹4,071Cr
Rev Gr TTM
Revenue Growth TTM
8.11%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

GMMPFAUDLR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 23.8 | 23.4 | 20.2 | 8.0 | -14.5 | -13.9 | -14.1 | -6.4 | 8.9 | 1.2 | 12.0 | 10.2 |
| 772 | 782 | 795 | 742 | 651 | 697 | 712 | 706 | 723 | 694 | 781 | 779 |
Operating Profit Operating ProfitCr |
| 10.9 | 14.3 | 15.2 | 13.3 | 12.1 | 11.3 | 11.6 | 12.0 | 10.3 | 12.7 | 13.5 | 11.9 |
Other Income Other IncomeCr | 15 | 9 | 9 | -8 | 11 | 10 | -1 | 26 | -52 | 9 | 9 | -48 |
Interest Expense Interest ExpenseCr | 21 | 20 | 22 | 23 | 30 | 25 | 26 | 25 | 27 | 43 | 30 | 34 |
Depreciation DepreciationCr | 36 | 38 | 36 | 36 | 39 | 35 | 36 | 35 | 38 | 36 | 36 | 37 |
| 51 | 80 | 93 | 47 | 31 | 38 | 30 | 62 | -34 | 32 | 64 | -14 |
| 18 | 30 | 26 | 19 | 6 | 17 | 15 | 22 | -6 | 21 | 25 | -5 |
|
Growth YoY PAT Growth YoY% | 93.0 | -18.7 | -30.4 | 49.6 | -24.2 | -56.3 | -77.4 | 43.3 | -210.6 | -53.5 | 158.4 | -122.2 |
| 3.9 | 5.5 | 7.2 | 3.3 | 3.4 | 2.8 | 1.9 | 5.0 | -3.5 | 1.3 | 4.4 | -1.0 |
| 8.6 | 12.2 | 15.2 | 6.4 | 6.9 | 5.2 | 3.4 | 9.2 | -6.0 | 2.5 | 9.2 | -1.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -5.1 | 20.9 | 14.9 | 23.9 | 17.6 | 69.4 | 153.8 | 25.1 | 8.5 | -7.2 | 5.9 |
| 272 | 257 | 306 | 344 | 426 | 480 | 862 | 2,257 | 2,748 | 2,971 | 2,838 | 2,976 |
Operating Profit Operating ProfitCr |
| 11.7 | 12.0 | 13.5 | 15.3 | 15.3 | 18.8 | 13.9 | 11.2 | 13.5 | 13.8 | 11.3 | 12.1 |
Other Income Other IncomeCr | 3 | 4 | 6 | 9 | 8 | 6 | -10 | 7 | 30 | 20 | -17 | -82 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 3 | 10 | 25 | 67 | 95 | 103 | 133 |
Depreciation DepreciationCr | 10 | 8 | 8 | 10 | 11 | 21 | 50 | 133 | 122 | 150 | 144 | 148 |
| 28 | 30 | 44 | 61 | 73 | 92 | 68 | 133 | 271 | 251 | 96 | 48 |
| 9 | 10 | 13 | 18 | 23 | 21 | 5 | 58 | 61 | 80 | 47 | 35 |
|
| | 6.6 | 54.7 | 37.1 | 18.5 | 40.6 | -10.7 | 18.6 | 179.2 | -18.9 | -71.2 | -74.2 |
| 6.1 | 6.9 | 8.8 | 10.5 | 10.1 | 12.0 | 6.3 | 3.0 | 6.6 | 5.0 | 1.5 | 0.4 |
| 4.3 | 4.6 | 7.1 | 9.7 | 11.5 | 16.2 | 16.7 | 6.5 | 37.5 | 39.0 | 11.8 | 3.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 9 | 9 | 9 | 9 |
| 148 | 164 | 191 | 225 | 266 | 326 | 403 | 524 | 792 | 955 | 1,014 | 1,167 |
Current Liabilities Current LiabilitiesCr | 80 | 84 | 114 | 144 | 145 | 164 | 813 | 1,071 | 1,391 | 1,165 | 1,131 | 1,419 |
Non Current Liabilities Non Current LiabilitiesCr | 4 | 4 | 11 | 17 | 21 | 36 | 1,083 | 988 | 1,160 | 1,038 | 943 | 1,229 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 177 | 192 | 253 | 308 | 345 | 390 | 1,323 | 1,689 | 2,072 | 1,852 | 1,884 | 2,354 |
Non Current Assets Non Current AssetsCr | 58 | 64 | 65 | 81 | 89 | 140 | 1,095 | 1,039 | 1,291 | 1,322 | 1,219 | 1,498 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 30 | 25 | 22 | 68 | 27 | 27 | 157 | 236 | 185 | 284 | 378 |
Investing Cash Flow Investing Cash FlowCr | -15 | -18 | -21 | -24 | -8 | -50 | -66 | -117 | -311 | -32 | -52 |
Financing Cash Flow Financing Cash FlowCr | -6 | -6 | -6 | -8 | -10 | -5 | 105 | -55 | 130 | -244 | -201 |
|
Free Cash Flow Free Cash FlowCr | 23 | 11 | 8 | 44 | 13 | -9 | 79 | 108 | 161 | 221 | 318 |
| 159.7 | 122.6 | 72.2 | 158.7 | 53.5 | 37.5 | 246.6 | 313.7 | 87.8 | 166.3 | 769.0 |
CFO To EBITDA CFO To EBITDA% | 83.8 | 70.5 | 47.3 | 109.1 | 35.1 | 24.0 | 112.9 | 83.3 | 43.0 | 59.7 | 104.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 418 | 368 | 761 | 1,005 | 1,754 | 3,675 | 6,293 | 6,671 | 6,590 | 5,556 | 4,553 |
Price To Earnings Price To Earnings | 23.3 | 19.2 | 24.5 | 23.5 | 34.7 | 51.6 | 85.6 | 78.3 | 40.3 | 31.6 | 86.0 |
Price To Sales Price To Sales | 1.4 | 1.3 | 2.2 | 2.5 | 3.5 | 6.2 | 6.3 | 2.6 | 2.1 | 1.6 | 1.4 |
Price To Book Price To Book | 2.8 | 2.2 | 3.9 | 4.4 | 6.5 | 11.2 | 15.5 | 12.6 | 8.2 | 5.8 | 4.5 |
| 10.3 | 9.0 | 15.4 | 15.1 | 21.8 | 32.7 | 47.8 | 24.6 | 16.8 | 12.9 | 13.7 |
Profitability Ratios Profitability Ratios |
| 56.5 | 58.7 | 57.7 | 58.5 | 53.7 | 57.0 | 55.3 | 60.1 | 59.6 | 60.0 | 60.7 |
| 11.7 | 12.0 | 13.5 | 15.3 | 15.3 | 18.8 | 13.9 | 11.2 | 13.5 | 13.8 | 11.3 |
| 6.1 | 6.9 | 8.8 | 10.5 | 10.1 | 12.0 | 6.3 | 3.0 | 6.6 | 5.0 | 1.5 |
| 19.1 | 18.3 | 23.2 | 27.1 | 27.7 | 26.4 | 7.5 | 13.6 | 19.0 | 18.5 | 10.7 |
| 12.5 | 12.1 | 16.1 | 18.7 | 18.8 | 21.6 | 15.6 | 14.3 | 26.3 | 17.7 | 4.8 |
| 8.1 | 7.9 | 9.8 | 11.0 | 11.6 | 13.4 | 2.6 | 2.8 | 6.3 | 5.4 | 1.6 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
GMM Pfaudler Limited is a globally integrated leader in corrosion-resistant process technologies, systems, and services for the chemical, pharmaceutical, biotech, food & beverage, energy, and emerging green technology sectors. With over six decades of heritage since its inception in 1962, the company has evolved from an India-centric manufacturer into a truly global player, operating **19 manufacturing facilities across four continents** and serving over **90% of the world’s top chemical companies**.
The company is the **market leader in glass-lined equipment (GLE)**, holding 40–50% market share in key regions and commanding near-monopoly status in large-vessel segments. However, strategic diversification beyond GLE has redefined its growth trajectory, positioning it as a **one-stop provider of integrated process solutions**.
---
### **Strategic Positioning & Growth Drivers**
#### 1. **Expansion into High-Growth Markets**
- **Peptides & Semaglutide Manufacturing**: Actively executing a large contract with a peptide manufacturer in Southern India, leveraging proprietary **HPPS reactor technology** and advanced filtration systems developed via its Swiss subsidiary **Mavag**.
- **Semiconductor & Nuclear Sectors**: The **Edlon** subsidiary in the U.S. is experiencing strong demand from the semiconductor industry. The acquisition of **HDO in Vatva, India**, has enabled entry into the nuclear sector, unlocking a new high-value growth avenue.
- **Electric Vehicles (EV) & Green Technologies**: Exploring opportunities in EV battery production and is developing technology platforms for **bio-proteins, bioplastics, and mock meat**.
#### 2. **Diversification Beyond Core Glass-Lined Business**
- Revenue from **glass-lined equipment (GLE)** has declined to around **~50% of total revenue** (from 80–90% historically), with active efforts underway to achieve a **balanced split: 1/3 equipment, 1/3 systems, 1/3 services**.
- Strategic goal: Transition from cyclical dependence on chemicals and pharma (now ~60% of business) to more stable, diversified industries including **oil & gas, petrochemicals, mining, defense, and water treatment**.
- The **non-GLE (glass-lined)** portfolio now includes:
- **Mixing technology** (via Mixion, Mixel, MixPro, SEMCO)
- **Filtration & Drying** (Mavag)
- **Sealing Tech** (Interseal)
- **Alloy Equipment** (Equilloy)
- **Fluoropolymers** (Edlon)
- **Lab & Process Glass** (Normag)
#### 3. **Global Mixing Platforms – A Growth Engine**
- Completed integration of **four mixing technology platforms**:
- **SEMCO (Brazil) – Metals, Minerals, Water Treatment**
- **MixPro (Canada) – Oil & Gas, Pulp & Paper**
- **Mixel (France/China) – Biotech, Petrochemicals**
- **Mixion (India) – Chemicals, Fermentation**
- **Global mixing business valued at ~$65 million**, with a **serviceable addressable market of $3 billion**.
- Recently acquired **SEMCO** for **$18.5 million** to establish a South American foothold and access fast-growing mining and water treatment markets.
- Mixing systems offer high margins (up to **30%+ EBITDA**) and serve critical applications like fermentation, flue gas desulfurization (FGD), and biorefining.
---
### **Operational Excellence & Global Manufacturing Strategy**
#### 1. **Manufacturing Rationalization & Offshoring**
- Actively shifting fabrication to **lower-cost hubs**:
- **India**: Exporting ASME-certified equipment to the U.S.; transferring engineering, documentation, and production activities to improve throughput.
- **Poland**: New joint venture facility operating at full capacity, serving Mavag and Switzerland; functioning as a low-cost European manufacturing hub.
- Retains **local engineering, testing, and service capabilities** in higher-cost regions (U.S., Germany, Switzerland) to meet local content and quality expectations.
#### 2. **Capacity Expansion & Infrastructure**
- In India, the **Karamsad and Vatva (Ahmedabad)** facilities are key enablers of growth:
- Commissioned India’s largest **80,000-liter glass-lined furnace** in Karamsad.
- State-of-the-art **Vatva Heavy Engineering facility** equipped to handle exotic alloys, thick-walled vessels, and nuclear-grade equipment.
- **Poland JV** and **U.S. local manufacturing** further strengthen regional resilience and cost competitiveness.
#### 3. **Test & Innovation Centers**
- Established **pilot and test centers** in **Karamsad (India), Switzerland, and North America** to enable customer trials.
- Supports **flow chemistry**, continuous manufacturing, molecular distillation, acid concentration, and filtration validation.
- Collaborating with **CSIR-NCL (India)** and **CPI (UK)** on decarbonization and continuous process technologies.
---
### **Technology & Innovation**
#### 1. **Proprietary Technologies**
- **HPPS Reactor Technology**: Proprietary, high-performance system critical for peptide manufacturing.
- **MoSA Process**: In-house developed **Modular Sulfuric Acid concentration** for sustainable acid recovery from flue gas; successfully commissioned plants in Korea, China, and India.
- **MAVASPHERE® Spherical Dryers**: Proven to reduce drying time from **100+ hours to under 24**, improving efficiency and ROI.
- **Funda® Filter & Continuous Pressure Filter (CPF)**: Designed for viscous and challenging filtrations in specialty chemicals.
#### 2. **Flow Chemistry & Continuous Processing**
- Developing capabilities in **continuous manufacturing**, including pilot reactors and **lab-to-industrial scale deployment**.
- Flow reactors see growing adoption in pharmaceuticals, especially for **exothermic or hazardous reactions**.
- Investment in automation, digitalization, and process simulation to support future trends.
---
### **Market Performance & Financial Outlook**
#### 1. **Strong Order Backlog**
- **Heavy Engineering** in India holds a significant pipeline, driven by nuclear, oil & gas, and refinery expansion projects (~₹60–100 crores per ticket).
- **SEMCO Brazil** has a **one-year order backlog**, with large opportunities in metals and minerals.
- Systems order book shows strong traction:
- **Acid recovery systems** (Korea, India, China)
- **Peptide equipment in Hastelloy & stainless steel**
- **Cardanol extraction skids and CNSL-to-biochemicals plants**
#### 2. **Revenue Diversification & Margins**
- Services now contribute **~30% of revenue**, marked by high margins and recurring business (spares, re-glassing, field service).
- The **mixing business**, while currently smaller, has higher margins and faster growth potential than traditional GLE.
- Management aims for **double-digit revenue growth in India**, with stable, moderate growth internationally.
---
### **Geographic Trends**
| **Region** | **Key Dynamics** |
|-----------|------------------|
| **India** | Strong demand in agrochemicals (resuming capex), pharma (PLI-driven), oil & gas (~6% sector growth), and nuclear. Gujarat facility at **above absorption capacity**. |
| **USA** | Local manufacturing base; strength in defense, semiconductors (Edlon), and services. |
| **Europe** | Divergent: **Southern & Eastern Europe stronger**; **Germany sluggish** due to capex constraints. Polish facility supports European demand. |
| **South America** | Rapid expansion via **SEMCO** in mining, wastewater, and renewable fuels. |
| **Southeast Asia & Middle East** | Strategic focus for international expansion through agent networks and vendor approvals. |
---
### **Key Acquisitions & Integration**
- **SEMCO (Brazil)** – Acquired in 2025: $65M global mixing platform now unified.
- **Mixel (France/China)** & **MixPro (Canada)**: Completed in 2023; enabled global scale in mixing.
- **Hydro Air Research Italia (HARI)**: Advanced **membrane separation tech** for green applications (water, bioplastics, lithium purification).
- **HDO (Vatva, India)**: Enabled entry into **nuclear and heavy engineering**.
- **Full acquisition of Pfaudler Group**: Made GMM Pfaudler the **ultimate holding company**, unlocking earnings, synergies, and consolidated global control.
---
### **Strategic Vision**
GMM Pfaudler is transforming from a niche **glass-lined equipment supplier** into a **global leader in integrated process systems**. The strategic pillars include:
1. **Diversification** – Reduce reliance on chemicals/pharma, grow systems and services.
2. **Globalization** – Expand manufacturing, sales, and service footprint.
3. **Innovation** – Lead in flow chemistry, acid recovery, and green technologies.
4. **Operational Excellence** – Leverage India for cost-effective manufacturing and engineering support.
5. **Integration & Cross-Selling** – Unify brands under a single global portfolio to deepen customer relationships.
---